Growth Differentiation Factor 15 in Severe Aortic Valve Stenosis: Relationship with Left Ventricular Remodeling and Frailty
Authors:
- Iacopo FabianiIFIacopo Fabiani
- Tatiana SantoniTSTatiana Santoni
- Marco AngelillisMAMarco Angelillis
- Serena PetricciuoloSPSerena Petricciuolo
- Andrea ColliACAndrea Colli
- Giovanni PellegriniGPGiovanni Pellegrini
- Deborah MazzeiDMDeborah Mazzei
- Nicola Riccardo PuglieseNPNicola Riccardo Pugliese
- Anna Sonia PetronioAPAnna Sonia Petronio
- Raffaele De CaterinaRaffaele De Caterina
Open Access
- 17 September 2020
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (9) , 2998
Abstract
Background: Frailty is an important outcome predictor in patients with aortic stenosis who are candidates for transcatheter or surgical aortic valve replacement (AVR). Growth/differentiation factor 15 (GDF15) is a cytokine playing a role in the pathophysiology of ventricular remodeling. We assessed its potential role as an independent soluble biomarker of frailty in these patients. Methods: We studied 62 patients (age, mean 79 years, 95% confidence interval (CI) 77–81; 54.8% female) with severe aortic valve stenosis and candidates for AVR. We systematically assessed pre-intervention GDF15 levels for their relationship with frailty (Katz score) and echocardiographic parameters of left ventricular dysfunction/remodeling. Fifteen hypertensive patients with left ventricular (LV) hypertrophy served as controls. Results: Patients with aortic valve stenosis featured higher GDF15 levels than controls (1773, 95% CI 1574–1971 pg/mL vs. 775, 95% CI 600–950 pg/mL, respectively, p < 0.0001). Subjects in the upper GDF15 tertile were older (p = 0.004), with a more advanced NYHA functional class (p = 0.04) and a higher prevalence of impaired renal function (p = 0.004). Such patients also showed a higher frailty score (p = 0.04) and higher indices of LV dysfunction, including reduced global longitudinal strain (p = 0.01) and a higher left ventricular mass (p = 0.001). GDF15 was significantly related to the Katz score, and predicted (OR 1.05; 95% CI 0.9–1.1; p = 0.03) a low (<5) Katz score, independent of the relationship with LV mass, age, renal function or indices of LV dysfunction. Conclusions: GDF15 is increased in patients with severe aortic stenosis and appears to be a soluble correlate of patients’ frailty, independent of indices of left ventricular dysfunction.Keywords
Funding Information
- Roche Italia (00045)
This publication has 44 references indexed in Scilit:
- Frailty Consensus: A Call to ActionJournal of the American Medical Directors Association, 2013
- The Association of Growth Differentiation Factor-15 with Left Ventricular Hypertrophy in Hypertensive PatientsPLOS ONE, 2012
- The Impact of Frailty Status on Survival After Transcatheter Aortic Valve Replacement in Older Adults With Severe Aortic StenosisJACC: Cardiovascular Interventions, 2012
- Evaluation of Multidimensional Geriatric Assessment as a Predictor of Mortality and Cardiovascular Events After Transcatheter Aortic Valve ImplantationJACC: Cardiovascular Interventions, 2012
- GDF-15 is increased during early reperfusion following aortic valve replacementScandinavian Cardiovascular Journal, 2012
- The TGF-β superfamily cytokine, MIC-1/GDF15: A pleotrophic cytokine with roles in inflammation, cancer and metabolismGrowth Factors, 2011
- Serial Measurement of Growth-Differentiation Factor-15 in Heart FailureCirculation, 2010
- Frail Patients Are at Increased Risk for Mortality and Prolonged Institutional Care After Cardiac SurgeryCirculation, 2010
- Prognostic Utility of Growth Differentiation Factor-15 in Patients With Chronic Heart FailureJACC, 2007
- Studies of Illness in the AgedJAMA, 1963